Larson Financial Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.3K Buy
322
+75
+30% +$9.08K ﹤0.01% 1703
2026
Q1
$40.4K Sell
247
-9
-4% -$1.38K ﹤0.01% 1460
2025
Q4
$44.6K Buy
256
+148
+137% +$27K ﹤0.01% 1288
2025
Q3
$15.6K Buy
108
+98
+980% +$12K ﹤0.01% 1780
2025
Q2
$1.01K Sell
10
-43
-81% -$3.29K ﹤0.01% 2653
2025
Q1
$4.04K Buy
+53
New +$4.05K ﹤0.01% 1941

Other funds holding INSM

Larson Financial Group's INSM Position: Q2 2026 in Review

Larson Financial Group increased its Insmed (INSM) stake by 30% in Q2 2026, buying an estimated $9.08K and bringing the position to 322 shares worth $34.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Larson Financial Group first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $44.6K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Larson Financial Group held 322 shares of Insmed worth $34.3K as of Q2 2026.
  • Larson Financial Group bought 75 Insmed shares in Q2 2026, an estimated $9.08K.
  • Insmed made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1703 holding.
  • Larson Financial Group first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Insmed position peaked at $44.6K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.